Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis

Fig. 2

Pooled analyses of each endpoint. Black dot at the left side represents the estimated hazard ratio obtained using the Kaplan–Meier curve. a Pooled analysis of overall survival (OS). b Pooled analysis of progression-free survival (PFS). c Pooled analysis of objective response rate (ORR). IRI, irinotecan; Ox, oxaliplatin; and CI, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us